These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 30394624)
1. Suppression, disaggregation, and modulation of γ-Synuclein fibrillation pathway by green tea polyphenol EGCG. Roy S; Bhat R Protein Sci; 2019 Feb; 28(2):382-402. PubMed ID: 30394624 [TBL] [Abstract][Full Text] [Related]
2. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease. Zaidi FK; Deep S Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603 [TBL] [Abstract][Full Text] [Related]
3. Cyclic-NDGA Effectively Inhibits Human γ-Synuclein Fibrillation, Forms Nontoxic Off-Pathway Species, and Disintegrates Preformed Mature Fibrils. Singh SL; Bhat R ACS Chem Neurosci; 2024 May; 15(9):1770-1786. PubMed ID: 38637513 [TBL] [Abstract][Full Text] [Related]
4. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein. Teng Y; Zhao J; Ding L; Ding Y; Zhou P Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122 [TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin Gallate Destabilizes α-Synuclein Fibril by Disrupting the E46-K80 Salt-Bridge and Inter-protofibril Interface. Yao Y; Tang Y; Wei G ACS Chem Neurosci; 2020 Dec; 11(24):4351-4361. PubMed ID: 33186020 [TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins. Jain MK; Singh P; Roy S; Bhat R Biochemistry; 2018 Jul; 57(26):3830-3848. PubMed ID: 29851342 [TBL] [Abstract][Full Text] [Related]
7. Green Tea Polyphenol Microparticles Based on the Oxidative Coupling of EGCG Inhibit Amyloid Aggregation/Cytotoxicity and Serve as a Platform for Drug Delivery. Fernandes L; Messias B; Pereira-Neves A; Azevedo EP; Araújo J; Foguel D; Palhano FL ACS Biomater Sci Eng; 2020 Aug; 6(8):4414-4423. PubMed ID: 33455167 [TBL] [Abstract][Full Text] [Related]
8. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors. Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299 [TBL] [Abstract][Full Text] [Related]
9. The Anthocyanidin Peonidin Interferes with an Early Step in the Fibrillation Pathway of α-Synuclein and Modulates It toward Amorphous Aggregates. Verma G; Bhat R ACS Chem Neurosci; 2023 Apr; ():. PubMed ID: 37011370 [TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson's Disease. Xu Y; Zhang Y; Quan Z; Wong W; Guo J; Zhang R; Yang Q; Dai R; McGeer PL; Qing H Neurochem Res; 2016 Oct; 41(10):2788-2796. PubMed ID: 27364962 [TBL] [Abstract][Full Text] [Related]
12. The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios. Wobst HJ; Sharma A; Diamond MI; Wanker EE; Bieschke J FEBS Lett; 2015 Jan; 589(1):77-83. PubMed ID: 25436420 [TBL] [Abstract][Full Text] [Related]
13. Modulation of the conformation, fibrillation, and fibril morphologies of human brain α-, β-, and γ-synuclein proteins by the disaccharide chemical chaperone trehalose. Jain MK; Bhat R Biochim Biophys Acta Proteins Proteom; 2023 Sep; 1871(5):140932. PubMed ID: 37433401 [TBL] [Abstract][Full Text] [Related]
14. EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the 'Active Oligomer' of α-Synuclein. Yang JE; Rhoo KY; Lee S; Lee JT; Park JH; Bhak G; Paik SR Sci Rep; 2017 Dec; 7(1):17945. PubMed ID: 29263416 [TBL] [Abstract][Full Text] [Related]
15. How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein. Andersen CB; Yoshimura Y; Nielsen J; Otzen DE; Mulder FAA J Biol Chem; 2021; 296():100788. PubMed ID: 34019875 [TBL] [Abstract][Full Text] [Related]
16. EGCG attenuates α-synuclein protofibril-membrane interactions and disrupts the protofibril. Yang Z; Yao Y; Zhou Y; Li X; Tang Y; Wei G Int J Biol Macromol; 2023 Mar; 230():123194. PubMed ID: 36623616 [TBL] [Abstract][Full Text] [Related]
17. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway. Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561 [TBL] [Abstract][Full Text] [Related]
18. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases. Gonçalves PB; Sodero ACR; Cordeiro Y Biomolecules; 2021 May; 11(5):. PubMed ID: 34065606 [TBL] [Abstract][Full Text] [Related]
19. Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine. Jain MK; Bhat R Neurobiol Dis; 2014 Mar; 63():115-28. PubMed ID: 24269918 [TBL] [Abstract][Full Text] [Related]
20. The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of Sternke-Hoffmann R; Peduzzo A; Bolakhrif N; Haas R; Buell AK Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]